Background: Combining quantitative proteomics and functional analysis, we have recently demonstrated that SLBP restricts the integration and transcription of HIV-1. In lymphocytic cells, SLBP depletion leads to the concomitant decrease of the restriction factor APOBEC3G (apolipoprotein B mRNAediting, enzyme-catalytic, polypeptide-like 3G). This decrease was observed at both the RNA and protein levels. Here, we sought to provide mechanistic insight into the novel SLBP/APOBEC3G relationship on the molecular level. Methodology: First, using EpiQ™ chromatin analysis, we compared promoter accessibility in lymphocytic cells under-expressing SLBP vs control samples. Then, chromatin Immunoprecipitation (ChIP) assay was employed to examine the binding affinity of specific transcription factors to APOBEC3G promoter regions. Finally, interferon PCR Arrays were performed to characterize potential molecules mediating interactions between SLBP and APOBEC3G. Results: SLBP depletion led to a significant (p<0.05) decrease in chromatin accessibility of the APOBEC3G gene in CEM cells. Also under conditions of SLBP depletion, ChIP revealed less binding of SP1, a known APOBEC3G transcription factor, to the -150 to -50 (relative to transcription start site) APOBEC3G promoter region. Finally, using interferon α, β response RT2 profiler™ PCR Arrays, SLBP depletion resulted in decreased level of IL15 (~10 fold), a known modulator for APOBEC3G. Conclusions: The synergistic expression of SLBP/APOBEC3G is likely due to the combined effects of SLBP-induced chromatin accessibility and transcription factor binding affinities of the APOBEC3G promoter region. SLBP depletion also impacts the interferon pathway to modulate APOBEC3G levels indirectly. These results identify SLBP as a regulator of APOBEC3G.